Developing and Launching New Products for Advanced Markets
First written in FY2016-Q3. 21 of 25 entries say "Advanced", first in FY2016. Latest entry: 2026-10-15.
24 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「Under Medium-Term Management Plan 2029, we have identified the fundamental strengthening of our research and development capabilities and the launch of next-generation core products as one of our key objectives. Beginning with the fiscal year ending August 2026, we will also launch a new product development project and begin developing products that could become our next core products.」
For new product development, the company states that the launch of next-generation core products is a key objective of Medium-Term Management Plan 2029 and that it began a new product development project in the fiscal year ending August 2026. It also sets out specific plans, including launching JIZAI in China and Japan and developing improved Vitreous Forceps. - FY2025AdvancedAnnual report
「In September 2024, we added the intermediate-size file JIZAI Pre 020 to the lineup. … Beginning in June 2025, we launched sales of the sterilized JIZAI series for Europe and North America.」
Following the addition of a new JIZAI product, the company progressed to launching sales of the sterilized series for Europe and North America. - FY2025-H1AdvancedAnnual report
「Beginning in September 2024, we launched JIZAI Pre 020, a new product in the JIZAI¹ series of NiTi rotary files for dental root canal treatment, designated as a priority development product under the medium-term management plan.」
For priority product JIZAI, the company reports the specific launch achievement of beginning sales of the new intermediate-size product JIZAI Pre 020 in September 2024. - FY2024AdvancedAnnual report
「In the fiscal year ended August 2024, we undertook initiatives including expanding the JIZAI product lineup in response to KOL demand for broader and higher-quality dental root canal treatment. … We also advanced initiatives including developing eyeless needles suitable for robotic surgery using MANI Hard Fiber Stainless Steel, our proprietary stainless-steel material.」
In addition to expanding the JIZAI lineup, the company is advancing the development and production of eyeless needles for robotic surgery, broadening the scope of its new product development. - FY2023AdvancedAnnual report
「We are strengthening marketing activities to establish mass production and expand sales of the JIZAI NiTi rotary file, a priority product under the medium-term management plan.」
For priority product JIZAI, the company has moved into the stage of strengthening marketing activities to expand sales following the establishment of a mass-production structure. - FY2023-Q3RestatedAnnual report
「During the fiscal year, we strengthened marketing activities to establish mass production and expand sales of the JIZAI NiTi rotary file, a priority product under the medium-term management plan, promoted domestic sales of the MANI Micro Forceps, and advanced sales activities for the dental restorative material in Europe.」
The company continues to establish a mass-production structure for its priority products, market JIZAI, promote domestic sales of the Vitreous Forceps and conduct sales activities for the dental restorative material in Europe. - FY2023-Q2AdvancedAnnual report
「During the fiscal year, we strengthened marketing activities to establish mass production and expand sales of the JIZAI NiTi rotary file, a priority product under the medium-term management plan, promoted domestic sales of the MANI Micro Forceps, and advanced the initial European sale of a new dental restorative material jointly developed by the company and its German consolidated subsidiary GDF.」
For its priority products, the company has progressed to the stage of strengthening JIZAI mass production and sales expansion activities, promoting domestic sales of the Vitreous Forceps and advancing the initial European sale of the dental restorative material. - FY2023-Q1AdvancedAnnual report
「During the fiscal year, we strengthened marketing activities to establish mass production and expand sales of the NiTi rotary file, a priority product under the medium-term management plan, and advanced preparations for the domestic launch of the Vitreous Forceps and the initial European sale of a dental restorative material sold under the MANI brand.」
For the priority NiTi rotary file, the company strengthened sales expansion activities following the establishment of a mass-production structure and advanced preparations for the next launch and sales phase, comprising the domestic launch of the Vitreous Forceps and the initial European sale of a dental restorative material. - FY2022-Q3AdvancedAnnual report
「In addition, we completed the regulatory registration and obtained regulatory approval for the Vitreous Forceps, which we had been developing as a priority product under the medium-term management plan. We also established a mass-production structure for the NiTi rotary file and are conducting marketing activities, including seminars to raise awareness, to expand sales.」
The company completed regulatory registration and obtained regulatory approval for the priority Vitreous Forceps, while advancing activities to raise awareness and expand sales of the NiTi rotary file through seminars and other initiatives following the establishment of a mass-production structure. - FY2022-Q2AdvancedAnnual report
「In addition, we established a mass-production structure for the NiTi rotary file, a priority product under the medium-term management plan, and advanced development of the new Vitreous Forceps for launch in the second half of the fiscal year.」
The company has established a mass-production structure for a priority product under the medium-term management plan and moved into the stage of advancing development toward the launch of a new product in the second half of the fiscal year. - FY2021-Q3RestatedAnnual report
「We have made shortening development timelines through the selection and concentration of development themes our top priority, and worked to establish a system for effectively concentrating resources on highly important themes.」
The company continues to prioritize shortening development timelines and concentrate resources on important themes. No new completion or achievement is stated. - FY2021-Q2AdvancedAnnual report
「We have worked to shorten development timelines by setting further selection and concentration among development themes as a goal, newly establishing a system for carefully selecting themes, and effectively concentrating resources on higher-priority themes.」
The company has moved into the stage of putting in place a system to carefully select development themes, concentrate resources on higher-priority themes and shorten development timelines. - FY2021-Q1RestatedAnnual report
「We have established a structure aimed at more efficient and effective development by setting further selection and concentration among development themes as a goal, carefully selecting themes with strong future potential and concentrating resources on the highest-priority themes.」
The company continues to pursue the selection and concentration of development themes and the allocation of resources to priority themes, as outlined in the previous fiscal year. No milestones such as new product launches are stated. - FY2020AdvancedAnnual report
「For our new product development structure, which had previously emphasized the number of new products launched, we will prioritize development themes, make our policy of selection and concentration more explicit, and seek to acquire new proprietary technologies, deepen our core technologies and accelerate time to market.」
Following the establishment of a project-based structure and a dedicated marketing department, the company has put into practice a development approach that prioritizes development themes and emphasizes selection and concentration, proprietary and core technologies, and speed to market. - FY2020-Q2AdvancedAnnual report
「During the six-month period ended [date], we launched JIZAI, a NiTi rotary file, as a new product expected to see expanding demand in future dental root canal treatment.」
As part of new product development, including expanding sales in developed markets, the company launched the JIZAI NiTi rotary file during the six-month period ended [date]. - FY2020-Q1AdvancedAnnual report
「In development, beginning in the previous fiscal year, we consolidated the development functions for the Surgical, Eyeless Needle and Dental segments, and, in addition to cross-segment technical exchange and shared equipment, shifted to a project-based structure that enables agile development management, thereby further accelerating new product development.」
The company implemented the planned shift to a project-based structure and moved into the stage of advancing new product development in combination with the consolidation of cross-segment development functions and technical exchange. - FY2019AdvancedAnnual report
「Beginning with the fiscal year ended August 2020, we shifted to a project-based structure organized by development theme to accelerate new product development, and newly established a dedicated marketing department.」
For new product development, the company implemented specific organizational changes, including a shift to a project-based structure organized by theme beginning with the fiscal year ended August 2020 and the establishment of a dedicated marketing department. - FY2018AdvancedAnnual report
「During the fiscal year, we launched the ENT Knife for otolaryngological surgery and the Side-Port Knife for ophthalmic surgery as new surgical products.」
Launched the ENT Knife for otolaryngological surgery and the Side-Port Knife for ophthalmic surgery as new surgical products. - FY2017AdvancedAnnual report
「During the fiscal year, we launched the Lift-Up Needle as a new product among our eyeless needle-related products and the Ophthalmic Trocar as an improved product among our surgical products.」
In addition to the previously reported Lift-Up Needle, an improved Ophthalmic Trocar was launched during the fiscal year. - FY2017-Q3AdvancedAnnual report
「In addition, during the nine-month period ended [date], we launched the Lift-Up Needle as a new product among our eyeless needle-related products.」
Launched the Lift-Up Needle as a new eyeless needle-related product. - FY2016AdvancedAnnual report
「During the consolidated fiscal year, we launched the Slit Knife (Short Head), Straight Knife (with marking) and 27G Port Knife as surgical-related products, and the Surgical Bar (with an additional MZB type) as a dental-related product.」
During the fiscal year, we launched 3 surgical-related products and 1 dental-related product, adding specific new product launches to those previously reported. - FY2016-Q3First statedAnnual report
「During the cumulative third quarter consolidated period, we launched the Short Head ophthalmic knife, which incorporates new marking technology from the Short Head knife, as a surgical-related product, and the Surgical Bar, with an additional MZB type, as a dental-related product.」
During the cumulative quarterly period, we launched specific new products in the surgical-related and dental-related product categories.